Top Tweets for #ComCOV
@PeachesTweets @ResearchNBT @NorthBristolNHS Bravo Lord Lieutenant of Bristol @PeachesTweets for volunteering to help medical studies in the #COMCOV vaccine trial @NorthBristolNHS Hopefully the study will assist in better health protection for all.
I have now completed the #COMCOV vaccine trial, helped throughout by Nurse Liz Barnett at @ResearchNBT Hopefully the knowledge gained from the study will positively influence medical choices procedures worldwide.
Get your #boostershot for #COVID19 & #flujab
@NorthBristolNHS
Thank you so much Matthew Snape & @PlestedEmma for giving interesting insight in the COMCOV studies @OxfordVacGroup and Zoi Pana for her professional moderation of our #COMCOV vaccine trials webinar. The webinar will be online soon in case you missed it! #VaccinesSaveLives
#COMCOV #clinicaltrial #webinar TODAY! Registration still possible. Get updated on #COVID19 vaccine trials with Matthew Snape and #VACCELERATE.
Heterologous prime-boosting, mRNA -> adenovirus vaccine:
#COMCOV preprint data indicates that 1 dose #Astrazeneca ("ChAd") followed by 1 dose #Pfizer ("BNT") produces an immune response similar to that induced by 2 doses of Pfizer's mRNA COVID-19 vaccine.
https://t.co/SbFN6oM0Wg
Registration possible now for #COVID19 #COMCOV #webinar: https://t.co/P90VzJxbg4
#VaccinesSaveLives 💉
#COMCOV VACCINE TRIALS WEBINAR
September 15 14:00 CEST
by #VACCELERATE Matthew Snape @PlestedEmma @OxfordVacGroup @UniofOxford @EU_Commission @HorizonEU
Studies, goals, vaccination reactions, effectiveness, timing.
Registration from Sep 8: https://t.co/hU123GA317
#COMCOV VACCINE TRIALS WEBINAR
September 15 14:00 CEST
by #VACCELERATE Matthew Snape @PlestedEmma @OxfordVacGroup @UniofOxford @EU_Commission @HorizonEU
Studies, goals, vaccination reactions, effectiveness, timing.
Registration from Sep 8: https://t.co/hU123GA317
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - @TheLancet #ComCOV https://t.co/2Yytewwarg
@MyCombiVac Why so little publicity for the #ComCov and #ComCov2 trials? Surely valuable data for booster vax policy and to win over the vaccine-hesitant?
The @OxfordVacGroup’s Com-Cov vaccine trial is studying the use of different combinations of approved #COVID19 vaccines for the first and second immunisation doses.
More on the #ComCov study: https://t.co/b59IOQv8tA
#CovidVaccine #COVIDVaccination #VaccinesWork
Primer estudio que analiza todas las combinaciones posibles entre las vacunas de Pfizer y de AstraZeneca da resultados que avalan el intercambio de estas vacunas. (Estudio #ComCOV de Oxford, en revisión de pares ahora mismo para publicación en The Lancet).
https://t.co/aeXElHNsgQ
El estudio #ComCov demuestra una robusta respuesta inmunitaria cuando se utiliza la pauta #Vaxzevria /#Comirnaty
Pasos de evidencia científica hacia el uso de #VacunaCOVID19 heteróloga
Preprint:
🔗 https://t.co/bgXNqRkVfb
SARS-CoV-2: Wechsel des Impfstoffs kann Immunität verbessern: Oxford – Erwachsene, die nach dem Astrazeneca-Impfstoff Vaxzevria als 2. Dosis die Biontech/Pfizer-Vakzine Comirnaty erhielten,… https://t.co/4F0IqvkGLh #Studie #ComCOV #Lancet #COVID19 #heterologeImpfung
Combinar vacunas mejora la inmunidad?! Se acaban de publicar los esperadísimos resultados del estudio #ComCov 🇬🇧
Os doy las claves en este vídeo https://t.co/yI1nL2fHvh
#ComCov Study: Specific mixing of vaccines gives higher Covid protection:
“An #AstraZeneca-#Pfizer combination induced higher antibody and T-cell responses than the Pfizer-AstraZeneca combination.”
https://t.co/KtPYYO1WG1
BREAKING NEWS: Oxford study says mixing COVID-19 vaccines gives good protection https://t.co/QRcwzryH6H #ComCOV #Covid19 #MixAndMatch #OxfordStudy #vaccines
@iamkapilan @SriLankaTweet #COMCOV was done on people >50 & now there is a general tendency in the west to offer everyone a mRNA vaccine as 2nd dose.
If you weigh the S/E vs benefit, it makes sense to offer our elderly the mix as well.
But there will be a supply problem
Final call by @MoH_SriLanka
@SJisMe @OxfordVacGroup Great question.
The same #COMCOV study is looking at a 12 week dosing interval as well.
Results should be out in August.
@iamkapilan @SriLankaTweet @BBCWorld No, the mixing trial of #COMCOV showed that AZ/Pfizer has a much better immune response than AZ/AZ. So no need of a restart.
But a booster trial is also going on. #COVBOOST, which looks at a 3rd dose of Pfizer/AZ/Moderna/Novavax/Valneva/CureVac/J&J
https://t.co/SEJuYFLguV
1st dose #AstraZeneca
2nd dose #Pfizer
4 week interval, n=463
AZ/Pfizer mix produced antibodies X9 as much as AZ/AZ
*Pfizer/Pfizer produced best Ab response overall but highest T cell response was in mix
#COMCOV study @OxfordVacGroup
#VaccinatedSL https://t.co/mAitsZzEBg
Last Seen Hashtags on Sotwe
tiktoker18
Seen from Vietnam
brosis
Seen from Spain
creepshots
WELCOMERESELLER
Seen from United States
snapchat
Seen from United States
teenageee
Seen from United Kingdom
workforce_development
Seen from United States
anxiouspanda filter:videos
Seen from Norway
butterbeercandle
Seen from United States
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90.1M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.5M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.5M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers